Specialty
Clinical
Quality Improvement
Publications
Partners
ADCs in the Treatment of Breast Cancer and Gastric Cancer and Managing AEs Associated with ADCs : Episode 10
Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia
Centering discussion on a patient profile of HER2+ gastric cancer, experts in oncology discuss the occurrence of neutropenia with trastuzumab deruxtecan therapy.
EP: 1.Patient Profile 1: A Patient With HER2+ Metastatic BC Treated With T-DXd who Develops ILD
EP: 2.Adverse Event Management With T-DXd in Patients With Breast or Gastric Cancers
EP: 3.Management of Interstitial Lung Disease Related to T-DXd in Breast or Gastric Cancers
EP: 4.Selecting Appropriate Patients with MBC for T-DXd and Counseling for AEs
EP: 5.Sequencing Therapy in MBC in Second Line and Beyond
EP: 6.Patient Profile 2: A Patient With HER2+ MBC Treated With T-DM1 who Develops Neuropathy
EP: 7.Role of T-DM1 in Patients With HER2+ Breast and Gastric Cancers
EP: 8.Managing AEs With Trastuzumab Emtansine in Breast and Gastric Cancers
EP: 9.A Brief Review of Ongoing Clinical Trials of ADCs in Breast Cancer
Now Viewing
EP: 10.Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia
EP: 11.First- and Second-Line Treatment Options for HER2+ Gastric Cancer
EP: 12.T-DXd in HER2+ Gastric Cancer: Managing Neutropenia and Other AEs
EP: 13.Ongoing Clinical Trials With T-DXd in HER2+ Gastric Cancer
EP: 14.Patient Profile 4: A Patient with HER2+ Gastric Cancer Treated With T-DXd Who Develops Diarrhea
EP: 15.T-DXd in HER2+ Gastric Cancer: Educating Patients About Risk of Diarrhea
EP: 16.Role of the Broader Healthcare Team in Managing AEs Associated With T-DXd
EP: 17.Novel Clinical Trials With ADCs in Gastric Cancer
EP: 18.Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric Cancer
Related Videos
Related Content
